Open AccessRapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy
Author(s) -
Carmela Pinnetti,
Silvia Baroncelli,
P. Villani,
Massimo Fantoni,
Valerio Tozzi,
Andrea De Luca,
Roberto Cauda,
G. Anzidei,
Maria Cusato,
Mario Regazzi,
Marco Floridia,
Enrica Tamburrini
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq264
Subject(s) - raltegravir , antiretroviral therapy , tenofovir , medicine , pregnancy , human immunodeficiency virus (hiv) , virology , viral load , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom